| NATtrol MERS-S. cerevisiae Recombinant (NATCOV(MR)-BIO) is formulated with purified, intact yeast cells that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 0.6 mL of NATtrol Middle East Respiratory Syndrome-Coronavirus recombinant sequence in S. cerevisiae; the MERS specific sequence is less than 500 bp and represents a small, non-infectious portion of the virus. NATCOV(MR)-BIO is supplied in a purified protein matrix that mimics the composition of a true clinical specimen. NATtrol MERS-S. cerevisiae Recombinant is designed to evaluate the performance of nucleic acid tests for determination of the presence of MERS-Coronavirus RNA. NATCOV(MR)-BIO can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel. NATCOV(MR)-BIO contains intact yeast cells and should be run in a manner identical to that used for clinical specimens. THIS PRODUCT IS SOLD SINGULARLY OR IN CONBINATION WITH PRODUCT NATRPC2.1-BIO (Product name NATtrol Respiratory Panel 2 (RP2) Controls Plus) or WITH PRODUCT NATRVP2.1-BIO (Product name NATtrol Respiratory Verification Panel 2 Plus). Material Safety Data Sheet.pdf |
NATCOV(MR)-BIO NATtrol MERS-S. cerevisiae
HS 38221900 - Size: 0.6 ml - required temp. +2° to +8° C. - Origin: USA - Non hazardous biological reagents - Classification/Regulatory: RUO
Share this product:
Technical Features and Specifications
| Product Code | NATCOV(MR)-BIO |
|---|---|
| Origin | USA |
| BTN - HS | 38221900 |
| Size | 0.6 ml |
| KGS | 0.001 |
| Shipping Conditions | +2° to +8° C. |
| Platform | BioFire FilmArray |
| Classification/Permits | Non hazardous biological reagents/RUO |